Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Optimal Amount of Tissue Sampling in Contrast-Enhanced Stereotactic Biopsy (CESB)

NCT06062992 is registered in ClinicalTrials.gov with Zuyderland Medisch Centrum as lead sponsor.

NCT NCT06062992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06062992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Optimal Amount of Tissue Sampling in Contrast-Enhanced Stereotactic Biopsy (CESB)
Lead sponsor
Zuyderland Medisch Centrum
Phase
Observational
Overall status
Completed
Start date
October 13, 2023
Completion date
February 16, 2026
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer female, breast neoplasms